Log in
Request a free trial
Request a free trial
Log in
Products
Solutions
Data
News & Analysis
About
Blog
News & Analysis
driven by the PitchBook Platform
Articles
reports
All articles
All
Venture Capital
Private Equity
M&A
Tech
Europe
reports
Subscribe
Boston Scientific Buying Vessix, Providing an Exit for Multiple VCs
November 9, 2012
Share:
Boston Scientific
(NYSE: BSX) is acquiring venture-funded
Vessix Vascular
, maker of a catheter-based device to treat uncontrolled hypertension. The purchase price includes an upfront payment of $125 million, with milestone payments of up to $400 million. Vessix snagged its final financing in August 2011, landing $23 million of Series B funding from
Edmond de Rothschild Investment Partners
,
OrbiMed Advisors
,
CDF Dinova Venture Partners
,
NeoMed Management
,
Christopher Weil & Company
and
Fjord Ventures
.
Vessix Vascular
Surgical Devices
Laguna Hills, CA
$125 million
Corporate Acquisition
View details
Sellers
CDF Dinova Venture Partners
Christopher Weil & Company
Edmond de Rothschild Investment Partners
Fjord Ventures
NeoMed Management
OrbiMed Advisors
Buyer
Boston Scientific
(NYSE: BSX)
Legal Advisor
Latham & Watkins
Share:
Tags:
Private Equity,
Venture Capital
Related content
Load more
